Research Funding and the Long Road to Drug Discovery

Here is a very interesting article about the man behind Alimta, the first FDA approved drug for mesothelioma treatment.  “His find became tumors’ nemesis”
This article highlights and confirms our need to continue to grow the Mesothelioma Applied Research Foundation’s Research Grant Program.  Through our proven peer-review process, we are able to identify the best […]

Preparing for Therapy with Alimta and Cisplatin

Alimta also known as Pemetrexed is the first drug ever approved for use in mesothelioma.  It was approved following a large trial that compared Alimta/Cisplatin with single agent Cisplatin.  It was found that patients who received the combination had a survival advantage over Cisplatin alone. This combination is now considered to be the standard of care for […]